Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2002
06/25/2002US6410342 Method and apparatus for controlled photoelution
06/25/2002US6410341 Analytical test device and method for use in medical diagnoses
06/25/2002US6410340 Use of an 8.4 kDa protein as an immunophilin reagent in protein binding assays for immunosuppressive drugs
06/25/2002US6410339 Detecting defect of metabolism; obtain human, administer cortisol agonist, monitor cortisol generation, classify metabolic defect
06/25/2002US6410337 Method of platlet function analysis using platelet count
06/25/2002US6410336 Method reagent and kit for the detection of fecal occult blood
06/25/2002US6410335 Circulating insulin-like growth factor-I and prostate cancer risk
06/25/2002US6410334 Evaluating immune response of blood sample; obtain blood, incubate with anticoagulant, monitor sample for preferential chemical intermediates
06/25/2002US6410333 Assessment of human skin damage following exposure to harmful agents
06/25/2002US6410332 Sampling and analysis of reactions by trapping reaction components on a sorbent
06/25/2002US6410330 Classification and measurement of erythrocytes; obtain blood, incubate with lytic agent, classify and measure cell distributions
06/25/2002US6410318 Antibodies directed against binding-associated epitopes
06/25/2002US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
06/25/2002US6410276 Selective amplification of target polynucleotide sequences
06/25/2002US6410269 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
06/25/2002US6410263 Histidine kinase
06/25/2002US6410261 CIITA-interacting proteins and methods of use therefor
06/25/2002US6410255 Optical probes and assays
06/25/2002US6410252 Methods for measuring T cell cytokines
06/25/2002US6410251 Redox system
06/25/2002US6410249 Odorant receptors
06/25/2002US6410247 Nuclear matrix protein fluid assay
06/25/2002US6410245 Complexing; fusion proteins; quantitative analysis
06/25/2002US6410243 Crosslinking; separation
06/25/2002US6410241 Methods of screening open reading frames to determine whether they encode polypeptides with an ability to generate an immune response
06/25/2002US6410240 Complexing
06/25/2002US6410239 Identification and comparison of protein—protein interactions that occur in populations and identification of inhibitors of these interactors
06/25/2002US6410229 Expression monitoring by hybridization to high density nucleic acid arrays
06/25/2002US6410024 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
06/25/2002US6410013 Viral vectors for use in monitoring HIV drug resistance
06/25/2002US6409989 A free-flowing suspension of activated carbon particles ground and graded to <50 mu; antiagglomerants; grinding in a cylindrical rod mill in a chamber coated with a nonabrasive lining; accuracy
06/25/2002US6409969 Adjusting the accuracy of an exhaust gas sensor; internal combustion engines;
06/25/2002US6409926 Air and water purification using continuous breakpoint halogenation and peroxygenation
06/25/2002US6409909 Modular sensor system for the industrial process measurement technique
06/25/2002US6409774 Electrophoresis-assisted staining of materials
06/25/2002US6409681 Estrogen or estradiol need determination by vaginal or urethral acidity determination
06/25/2002US6409680 pH measurement of body fluid
06/25/2002US6409528 Device and method for collecting, preparation and stabilizing a sample
06/25/2002US6408702 Wood processing drier sensor
06/25/2002US6408683 Laboratory asphalt stability test and apparatus
06/25/2002CA2282042C Solid phase enzyme kinetics screening in microcolonies
06/25/2002CA2245462C Methods of modulating cell proliferation through telomerase modulation
06/25/2002CA2194393C Mammalian telomerase
06/25/2002CA2161778C Detection of prostate-specific antigen in breast tumors
06/25/2002CA2135648C Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
06/25/2002CA2112107C A method for detecting nitric oxide, nitrosonium equivalents, s-nitrosothiols and s-nitroso-proteins in biological systems
06/25/2002CA2092917C Hair analysis method
06/25/2002CA2085881C Dna encoding mammalian phosphodiesterases
06/25/2002CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof
06/23/2002WO2002040654A2 A human serpin secreted from lymphoid cells lsi-01
06/23/2002CA2429179A1 Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01
06/22/2002CA2365673A1 Methods, compositions and kits relating to cardiovascular disease
06/22/2002CA2365652A1 Filtering device
06/20/2002WO2002048898A1 Method for screening for inhibitors of alzheimer's disease
06/20/2002WO2002048717A2 Acid-labile isotope-coded extractant (alice) in mass spectrometric analysis
06/20/2002WO2002048716A2 Differential phage capture proteomics
06/20/2002WO2002048715A2 Inflammatory markers for detection and prevention of diabetes mellitus
06/20/2002WO2002048714A1 Method of cancer estimation by alp isozymes
06/20/2002WO2002048712A1 A method of detection of e-coli, other coliforms and pathogenic organisms in water
06/20/2002WO2002048711A1 Immunological assay reagents and assay method
06/20/2002WO2002048710A2 Method for determining concentrations of analytes
06/20/2002WO2002048709A1 Membrane signalling networks
06/20/2002WO2002048708A2 Assay for anti-viral agent
06/20/2002WO2002048707A2 Electrochemical coagulation assay and device
06/20/2002WO2002048705A2 Gas sensor calibration system
06/20/2002WO2002048703A1 Analytical element, and measuring instrument and substrate determining method using the same
06/20/2002WO2002048702A2 Material sensor with protective layer
06/20/2002WO2002048701A2 Nanosensors
06/20/2002WO2002048700A2 Method for classifying chemical substances according to olfactory characteristics
06/20/2002WO2002048698A1 Direct determination of acid distributions in crudes and crude fractions
06/20/2002WO2002048697A1 Method for interpreting tandem mass spectrometry data for clinical diagnosis
06/20/2002WO2002048692A1 Apparatus and method for imaging a histological sample
06/20/2002WO2002048691A1 Device for enhancing wideband fluorescence with low losses and biological or chemical optical sensor using same
06/20/2002WO2002048686A2 Method for detecting a gas using an infrared gas analyzer and gas analyzer suitable for carrying out said method
06/20/2002WO2002048685A1 Flow-through membrane assays for carbohydrates using labeled lectins
06/20/2002WO2002048676A2 Multiple array system for integrating bioarrays
06/20/2002WO2002048674A2 Methods, devices, arrays and kits for detecting and analyzing biomolecules
06/20/2002WO2002048672A2 Reagents and methods for use inn the detection of analytes
06/20/2002WO2002048671A1 Assay for paralytic shellfish toxin
06/20/2002WO2002048405A2 Non-invasive method for detecting target rna
06/20/2002WO2002048404A2 Method and kit for enhancing the association rates of polynucleotides
06/20/2002WO2002048403A2 Multiplexed protein expression and activity assay
06/20/2002WO2002048402A2 Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
06/20/2002WO2002048398A2 In situ hybridization system for specifically detecting microorganisms
06/20/2002WO2002048395A1 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states
06/20/2002WO2002048393A2 Light-activated in vitro assay process for luciferase bioluminescence
06/20/2002WO2002048392A2 Screening method for inhibitors of pyruvate orthophosphate dikinase
06/20/2002WO2002048391A2 Dormancy - induced mycobacterium proteins
06/20/2002WO2002048389A2 Focussing of compound libraries using atomic electrotopological values
06/20/2002WO2002048388A2 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
06/20/2002WO2002048386A2 Protein-protein interactions
06/20/2002WO2002048375A2 Purified active hcv ns2/3 protease
06/20/2002WO2002048370A2 Compositions and methods relating to colon specific genes and proteins
06/20/2002WO2002048368A2 Proteins associated with cell growth, differentiation, and death
06/20/2002WO2002048366A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/20/2002WO2002048365A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/20/2002WO2002048363A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
06/20/2002WO2002048360A1 Estrogen receptor genes and utilization thereof
06/20/2002WO2002048359A1 Magnetic particle membrane-specific protein
06/20/2002WO2002048358A2 Regulation of human chemokine-like receptor